SCHEMBL24815696

SCHEMBL24815696

O=C(CSc1ccc(F)cc1F)N1Cc2ccccc2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.51
TAS1R1 Q7RTX1 1/20 0.51
TAS1R2 Q8TE23 1/20 0.51
NPC1 O15118 2/20 0.44
RAB9A P51151 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.41
PDE4B Q07343 1/20 0.41
PDE4D Q08499 1/20 0.41
ALDH1A1 P00352 7/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PKM P14618 2/20 0.41
HSP90B1 P14625 2/20 0.41
TRAP1 Q12931 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.40
HSD17B10 Q99714 1/20 0.40
LMNA P02545 1/20 0.40
HSP90AA1 P07900 1/20 0.40
DPP8 Q6V1X1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29987128 1.00 TAS1R3 (0.51) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL24815694 0.89 TAS1R3 (0.48) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL29986737 0.89 TAS1R3 (0.48) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL24815726 0.87 PKM (0.47) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL24814444 0.86 PKM (0.49) NPC1RAB9AALDH1A1HPGDPKM
SCHEMBL29986217 0.86 PKM (0.49) NPC1RAB9AALDH1A1HPGDPKM
SCHEMBL24814446 0.81 PKM (0.50) NPC1RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL29987097 0.80 NPC1 (0.48) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL24814420 0.80 NPC1 (0.48) TAS1R3TAS1R1TAS1R2NPC1RAB9A
SCHEMBL24814709 0.78 FKBP1A (0.51) NPC1RAB9AL3MBTL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH TAS1R3 4201/4885TAS1R1 4472/4885TAS1R2 3699/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH TAS1R3 4201/4885TAS1R1 4472/4885TAS1R2 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.